This study is for people with cancer who are considering taking part in a research trial. The study is testing different doses of a special treatment called CART-19 cells. These cells are modified to help the body fight cancer. You must be able to receive the treatment and be followed for at least 3 months after the first dose. If the cancer comes back after an initial response, you might be eligible for retreatment with these cells.
Key Points:
- **Study Length:** You'll need to stay in the study for at least 3 months.
- **Visits Required:** The treatment is given in parts over three days, and you will have follow-up visits.
- **Eligibility:** This is for people who can handle the CART-19 cell treatment and follow-up.
The study aims to find the best dose of CART-19 cells to help treat cancer. Participants will receive the treatment in a sequence, and ongoing monitoring is important for the study. If you're interested, talk to your doctor to see if you qualify. 🧬
How understandable was the trial content above?
Hard to understand
Easy to understand